What You Should Know:
- Proscia®, a pathology AI company, has introduced a new virtual staining feature in its Concentriq® software platform.
- The technology, powered by Pictor Labs, is designed to help laboratories reduce the costs and time associated with traditional chemical staining methods. The virtual staining will also support the evolution from research applications to clinical use, expanding diagnostic possibilities.
Transforming Traditional Pathology
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Capital Rx Rebrands as Judi Health, Announces $400M Investment for Expansion
Capital Rx Rebrands as Judi Health, Announces $400M Investment for Expansion
What You Should Know:
- Capital Rx, Inc., an enterprise health technology company, has announced a significant milestone: a $400M investment, including a $252M Series F funding round. The company is also rebranding as Judi Health™.
- The new name is intended to reflect its expanded capabilities as a full-service health benefits technology company. The investment was led by Wellington Management and
Read More
The AI Paradox in Healthcare: Notable CEO Shares Why Moving Too Slowly is a Greater Risk
The healthcare industry stands at a critical juncture, facing mounting pressures from staffing shortages, financial constraints, and rising patient expectations. While the promise of AI to alleviate these burdens is widely acknowledged, many health systems are grappling with a paradox: a deep-seated enthusiasm for new technologies, yet a reluctance to move from governance to full-scale deployment.
In a recent interview, Pranay Kapadia, CEO and Co-Founder of Notable, shared his insights on
Read More
Glooko Acquires Monarch Medical to Unify Diabetes Management
What You Should Know:
- Glooko, a provider of remote patient monitoring and digital health solutions for diabetes, has acquired Monarch Medical Technologies, the developer of the EndoTool® Glucose Management System. Terms of the acquisition are not being disclosed.
- The strategic acquisition allows Glooko to expand its connected care capabilities into inpatient glycemic management, complementing its existing strength in outpatient diabetes management. The goal is to create a single,
Read More
Pfizer Acquires Metsera for $4.9B, Expanding into Obesity and Cardiometabolic Market
What You Should Know:
- Pfizer Inc. and Metsera, Inc. have entered into a definitive agreement under which Pfizer will acquire Metsera, a clinical-stage biopharmaceutical company focused on developing medicines for obesity and cardiometabolic diseases for $4.9B.
- The acquisition is a strategic move for Pfizer, allowing it to enter a significant and growing therapeutic area. The Boards of Directors of both companies have unanimously approved the transaction.
Financial Terms
Read More
Why Broken Analog Infrastructure Blocks Behavioral Health Innovation
Behavioral health has become a leading frontier for digital health innovation. From virtual therapy platforms to AI-powered diagnostics, the sector has drawn massive investment and attention. However, most behavioral health providers still operate in a system powered by faxes, phone calls, and fractured workflows. The tools may be new, but the terrain beneath them hasn’t changed. And that makes all the difference.
This is a blind spot for the healthtech
Read More
Until Labs Raises $58M to Pioneer Organ Cryopreservation and Medical Hibernation
What You Should Know:
- Until Labs, a company dedicated to the reversible cryopreservation of biological systems secures $58M in Series A funding led by Founders Fund, with participation from Lux Capital and Field Ventures.
- The funding will be used to grow the company's multidisciplinary team of experts in chemistry, biology, and engineering.
Solving the Organ Transplant Crisis
The company's primary focus is on organ-scale reversible cryopreservation. This technology
Read More
Heartflow Receives FDA Clearance for Next-Gen AI Plaque Analysis, Expands Cigna Coverage
What You Should Know:
- Heartflow, a leader in AI technology for coronary artery disease (CAD), has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Next Gen Heartflow Plaque Analysis algorithm and platform.
- The technology features an updated algorithm, an expanded nomogram, and advanced 3D color-coded visualization of plaque, empowering clinicians with crucial insights for confident care decisions. In addition, Heartflow announced that Cigna will
Read More
Lunit and Agilent Partner to Develop AI-Powered Companion Diagnostics for Cancer
What You Should Know:
- Lunit, a provider of AI for cancer diagnostics, and Agilent Technologies Inc., a global leader in life sciences, have announced a nonexclusive collaboration to develop AI-based companion diagnostic solutions.
- The strategic partnership will combine Lunit's AI technology with Agilent’s expertise in tissue-based companion diagnostics. The goal is to create advanced solutions that meet the demands of novel and complex biomarker assays in drug
Read More
MoldCo Raises $8M to Combat the “Invisible Health Crisis” of Mold Toxicity
What You Should Know:
- MoldCo, a telehealth platform specializing in the diagnosis and treatment of mold and environmental toxins, has announced it has raised $8M in seed funding co-led by Cantos and Collaborative Fund. The funding brings the company's total funding to $11M.
- The funding will be used to expand MoldCo's virtual clinic and advance its mission to make expert-led care for mold-related illness more affordable and accessible to patients nationwide.
Mold: The Invisible
Read More
